Sign in
CompletedNo phase

Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis

Key facts

Who runs it
University of Miami
Where
Miami, United StatesSee the site
Trial code
Status
Completed
People taking part
9 people enrolled
Started
8 Dec 2022
Ended
2 Jun 2026
Type of study
Interventional
Treatments tested
  • Embosphere Microspheres
Record updated
17 July 2026

Who can take part

Age
40 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Subject has signed informed consent
  • Subject is age 40-80
  • Subject is able to have an MRI
  • Minimum of prior 12 weeks of failed response to conservative therapy for knee osteoarthritis, which may include one or more of:; Oral or topical NSAIDS, opioid medications, intra-articular injection of glucocorticoids or hyaluronic acid, physical therapy
  • Localized tenderness in anterior knee area
  • Kellgren-Lawrence grade 1, 2, or 3 as assessed by weight-bearing knee radiographs
  • Synovitis present as assessed by WORMS
  • VAS >50 mm
  • WOMAC score >30

Who cannot take part

  • Prior knee arthroplasty
  • Local infection of the target knee(s)
  • Allergy to iodinated contrast agents that cannot be managed by prophylaxis
  • Hypersensitivity to gelatin products
  • Any known condition that limits catheter-based intervention or is a contraindication to embolization
  • Active malignancy other than non-melanomatous skin cancer
  • Any other condition related to the subject's health and wellbeing deemed exclusionary in the opinion of the investigator
  • Rheumatoid arthritis
  • Kellgren-Lawrence grade >3
  • Osteonecrosis evident by MRI
  • Subject is pregnant, breastfeeding, or pre-menopausal and intending to become pregnant

Where in United States

  • University of MiamiMiami, United States

About the trial

What the trial wants to find out

The purpose of this research study is to evaluate the effectiveness and safety of a permanent embolic (Embosphere Microspheres) for embolization of the geniculate artery for the treatment of moderate to severe knee osteoarthritis.

The group in the trial

  • Embosphere Microspheres groupTreatment being tested

    Participants in this group who are receiving standard of care (SOC) embolization surgery for the treatment of moderate to severe knee osteoarthritis will receive the Embospheres Microspheres during scheduled SOC surgery.

    Treatment: Embosphere Microspheres

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective, Single Arm Investigation to Assess Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis
Record updated
17 July 2026